RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      SCIE SCOPUS KCI등재

      무혈청배지를 이용한 양수줄기세포 배양 = Effective In Vitro Expansion of Amniotic Fluid-Derived Stem Cells in Serum Free Medium

      한글로보기

      https://www.riss.kr/link?id=A99586938

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Human stem cells are typically obtained for clinical application of cell therapy by isolating and subculturing adherent cells. The expansion of stem cells depends on the culture conditions and requires medium supplemented with fetal bovine serum (FBS) to generate relevant numbers of cells. However, the presence of FBS is a major obstacle for clinical use of the stem cells. Therefore, we have evaluated the capacity of expansion of amniotic fluid-derived stem cells (AFSCs) in a commercial serum-free medium in comparison with a conventional FBS-containing medium. AFSCs were expanded in two different culture media. Proliferation rate of the cells was higher in serum-free medium than in FBS-containing medium. Stem cells isolated in the both media were morphologically similar, and they were expressed identical surface antigens and mRNA of stem cell markers. AFSCs in the both media were also able to differentiate into the myogenic cells. These results suggest that a commercial serum-free medium (MesemCult-XF Medium) is an optimal medium for expansion of AFSCs. It allows a better cell expansion, preserves cell characteristics, and reduces the culture period. This medium seems suitable for clinical scale expansion of AFSCs.
      번역하기

      Human stem cells are typically obtained for clinical application of cell therapy by isolating and subculturing adherent cells. The expansion of stem cells depends on the culture conditions and requires medium supplemented with fetal bovine serum (FBS)...

      Human stem cells are typically obtained for clinical application of cell therapy by isolating and subculturing adherent cells. The expansion of stem cells depends on the culture conditions and requires medium supplemented with fetal bovine serum (FBS) to generate relevant numbers of cells. However, the presence of FBS is a major obstacle for clinical use of the stem cells. Therefore, we have evaluated the capacity of expansion of amniotic fluid-derived stem cells (AFSCs) in a commercial serum-free medium in comparison with a conventional FBS-containing medium. AFSCs were expanded in two different culture media. Proliferation rate of the cells was higher in serum-free medium than in FBS-containing medium. Stem cells isolated in the both media were morphologically similar, and they were expressed identical surface antigens and mRNA of stem cell markers. AFSCs in the both media were also able to differentiate into the myogenic cells. These results suggest that a commercial serum-free medium (MesemCult-XF Medium) is an optimal medium for expansion of AFSCs. It allows a better cell expansion, preserves cell characteristics, and reduces the culture period. This medium seems suitable for clinical scale expansion of AFSCs.

      더보기

      참고문헌 (Reference)

      1 Q You, "The biological characteristics of human third trimester amniotic fluid stem cells" 37 : 105-, 2009

      2 N Siegel, "Stem cells in amniotic fluid as new tools to study human genetic disease" 3 : 256-, 2007

      3 KM Zsebo, "Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor" 63 : 213-, 1990

      4 B Lindroos, "Serum-free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro" 11 : 958-, 2009

      5 HE Lu, "Selection of alkaline phosphatase-positive induced pluripotent stem cells from human amniotic fluid-derived cells by feeder free system" 317 : 1895-, 2011

      6 T Mirabella, "Recruitment of host’s progenitor cells to sites of human amniotic fluid stem cells implantation" 32 : 4218-, 2011

      7 RE Priest, "Origin of cells in human amniotic fluid cultures: ultrastructural features" 39 : 106-, 1978

      8 AR Prusa, "Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?" 18 : 1489-, 2003

      9 AR Prusa, "Neurogenic cells in human amniotic fluid" 191 : 309-, 2004

      10 MG Roubelakis, "Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells" 16 : 931-, 2007

      1 Q You, "The biological characteristics of human third trimester amniotic fluid stem cells" 37 : 105-, 2009

      2 N Siegel, "Stem cells in amniotic fluid as new tools to study human genetic disease" 3 : 256-, 2007

      3 KM Zsebo, "Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor" 63 : 213-, 1990

      4 B Lindroos, "Serum-free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro" 11 : 958-, 2009

      5 HE Lu, "Selection of alkaline phosphatase-positive induced pluripotent stem cells from human amniotic fluid-derived cells by feeder free system" 317 : 1895-, 2011

      6 T Mirabella, "Recruitment of host’s progenitor cells to sites of human amniotic fluid stem cells implantation" 32 : 4218-, 2011

      7 RE Priest, "Origin of cells in human amniotic fluid cultures: ultrastructural features" 39 : 106-, 1978

      8 AR Prusa, "Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?" 18 : 1489-, 2003

      9 AR Prusa, "Neurogenic cells in human amniotic fluid" 191 : 309-, 2004

      10 MG Roubelakis, "Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells" 16 : 931-, 2007

      11 P Bossolasco, "Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential" 16 : 329-, 2006

      12 A Bartholomew, "Mesenchymal stem cells Suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo" 30 : 42-, 2002

      13 JJ Minguell, "Mesenchymal stem cells" 226 : 507-, 2001

      14 J Jung, "Mesenchymal Stromal Cells Expanded in Human Allogenic Cord Blood Serum Display Higher Self-Renewal and Enhanced Osteogenic Potential" MARY ANN LIEBERT INC 18 (18): 559-571, 2009

      15 L Wu, "Literature review on population and childbirth research in china in 2006" 2 : 14-, 2008

      16 MS Tsai, "Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol" 19 : 1450-, 2004

      17 J Chen, "Isolation and characterization of porcine amniotic fluid-derived multipotent stem cells" 6 : 19964-, 2011

      18 A Nimura, "Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum" 58 : 501-, 2008

      19 A Shahdadfar, "In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability" 23 : 1357-, 2005

      20 V Mirabet, "Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissue" 9 : 1-, 2008

      21 K Schallmoser, "Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells" 47 : 1436-, 2007

      22 P DeCoppi, "Human fetal stem cell isolation from amniotic fluid" 201-, 2001

      23 김지영, "Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells" 40 : 75-90, 2007

      24 K Bieback, "Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow" 27 : 2331-, 2009

      25 SJ Kim, "Human adipose stromal cells expanded in human serum promote engraftment of human peripheral blood hematopoietic stem cells in NOD/SCID mice" ACADEMIC PRESS INC ELSEVIER SCIENCE 329 : 25-31, 2005

      26 JA Dahl, "Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum" 52 : 1033-, 2008

      27 K Polgar, "Characterization of rapidly adhering amniotic fluid cells by combined immunofluorescence and phagocytosis assays" 45 : 786-, 1989

      28 "Cell therapy and Gene therapy"

      29 I Muller, "Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM" 8 : 437-, 2006

      30 PS In’t Anker, "Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation" 102 : 1548-, 2003

      31 SS Tholpady, "Adipose tissue: stem cells and beyond" 33 : 55-, 2006

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      학술지등록 한글명 : 조직공학과 재생의학
      외국어명 : Tissue Engineering and Regenerative Medicine
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2013-10-01 평가 등재학술지 선정 (기타) KCI등재
      2012-01-01 평가 등재후보 1차 FAIL (기타) KCI등재후보
      2011-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2010-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2008-01-01 평가 SCIE 등재 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.08 0.42 0.81
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.69 0.51 0.367 0.03
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼